
Altamira Therapeutics Investor Relations Material
Latest events

H2 2024
Altamira Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Altamira Therapeutics Ltd
Access all reports
Altamira Therapeutics Ltd is a Switzerland-based biopharmaceutical company focused on developing and commercializing therapies for ear, nose, and throat (ENT) and central nervous system (CNS) disorders. The company's pipeline includes RNA-based therapeutics, as well as treatments for inner ear conditions such as tinnitus and vertigo. Altamira Therapeutics applies its proprietary delivery platforms to target therapeutic molecules effectively, aiming to address unmet medical needs across its key treatment areas. The company is headquartered in Hamilton, Bermuda, and its shares are listed on the NASDAQ.
Key slides for Altamira Therapeutics Ltd


Corporate Presentation
Altamira Therapeutics Ltd


Corporate Presentation
Altamira Therapeutics Ltd
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CYTO
Country
🇺🇸 United States